Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells

Published:2005 Issue:2 Volume:207 Page:156-163
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Blanchot-Jossic Frédérique,Jarry Anne,Masson Damien,Bach-Ngohou Kalyane,Paineau Jacques,Denis Marc G,Laboisse Christian L,Mosnier Jean-François

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

2. Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

3. Remarkable roles of proteolysis on and beyond the cell surface

4. An Essential Role for Ectodomain Shedding in Mammalian Development

5. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the association of ADAM17 expression with survival in patients with non-small cell lung cancer;Journal of Investigative Medicine;2024-08-28

2. m⁶A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling;International Journal of Oncology;2023-12-06

3. The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond;The FEBS Journal;2023-08-11

4. ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy;Cancer Gene Therapy;2023-07-26

5. Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer;Journal of Extracellular Vesicles;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3